policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
policy
Veterinary ergonomic guidelines
Discover risk factors that could lead to musculo-skeletal injury, examples of related tasks in veterinary medicine, and what to do if you identify a…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
Compounding: FAQs for veterinarians
Get answers to the compounding questions veterinarians most frequently ask the AVMA.
JAVMA news
Cephalosporin use restricted in livestock
The Food and Drug Administration is increasing restrictions on extralabel use of cephalosporin-class antimicrobials in most food animals starting…
JAVMA news
Looking ahead
Dr. Clark K. Fobian, District VII representative to the AVMA Executive Board, will likely be elected AVMA president-elect by the AVMA House of…
JAVMA news
No ruling coming in compounding dispute
A Florida pharmacy and federal drug authorities have fought for 2 1/2 years over the legality of compounding animal drugs from bulk pharmaceutical…
Controlled substances in veterinary practice
The veterinary toolbox includes vital medications that are regulated as controlled substances. Here's what veterinarians and veterinary teams need to…